Category: Events

GapSummit 2019

Broad Institute of Harvard and MIT, USA
June 16-20th 2019

GapSummit is the premier, global, intergenerational biotechnology summit that attracts world leaders and the next generation of leaders to substantively discuss pressing challenges facing the bioeconomy and catalyze innovation to address these challenges.

GapSummit competitively selects 100 Leaders of Tomorrow from around the world to attend the summit. We look for students, entrepreneurs and young professionals with a proven track record of leadership and expertise in the biotech field. GapSummit 2019 will provide Leaders of Tomorrow with an unparalleled opportunity to network with, challenge and learn from current world leaders in the biotech field. Leaders of Tomorrow will also gain a comprehensive overview of biotech trends and issues, inciting discussion about world challenges that will to be met by scientific and business innovations.

https://gapsummit.com

 

MIBio 2018: Stability of biopharmaceuticals – from molecular interactions to successful products

Thursday 15th November Downing College, Cambridge

The MIBio conference series engages world leading experts from industry and academia in a discussion in how the latest molecular interaction based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly and safer therapeutic products.

With growing competition in the market, patient-centric product strategies, an increasing variety of products in development and more complex regulatory requirements, the demand for formulation of therapeutic proteins are increasing. In addition, the formulation patent landscape is becoming more complicated which further contributes to the challenge of development robust dosage forms. MIBio 2018 will focus on discussing these challenges as well as strategies to overcome them, particularly focusing on formulation, drug product development and device and regulatory strategies.We expect more than 100 delegates from industry and academia to create an interesting and stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation formulation technologies. We will be inviting abstracts for poster submissions and welcome applications for sponsor and exhibitor slots on the day.

Student registration only £35!
More details https://www.formulation.org.uk/mibio-2018-information

 

Fujifilm Diosynth Biotechnologies Open Innovation Event

30 November 2018, 9.30am–4.00pm, Wilton Centre, Redcar

This event is an opportunity for small and medium sized businesses, spin-out companies and academics to meet key FDB personnel and find out more about our innovation strategy and open innovation opportunities. Companies are invited to pitch their technology-driven products, services or processes to FDB. This is a great opportunity for potential business partnerships with FDB to be formed. The networking sessions are also a chance to make new contacts and discover technologies that other businesses are developing. A tour of the FDB labs is also included.

Places are limited to register your interest ASAP. Closing date for applications is October 31st 2018. For any enquiries please email Jennifer.vanderhoven@fujifilm.com
Please complete the online application at https://goo.gl/forms/bbDUGgdYSw85XTg42

5th Annual Science Meeting

October 10-11th 2018
British Medical Association House, Central London

“The 2017 meeting was one of the most interesting and educational that I have attended in a while!”

Wednesday October 10th
9.30 Registration (if you arrive before registration you are welcome to use the BMA cafe)
10.15-10.30 Welcome, achievements and what next for BioProNET
Designing more efficient cell-expression systems chaired by Mark Smales
10.30-10.55 Kerstin Otte
 University of Applied Science Biberach, Germany Identification and characterisation of intracellular production bottlenecks in CHO cells producing complex biopharmaceuticals
10.55-11.20 Colin Robinson University of Kent Development of next generation E. coli platforms for the regulated production and periplasmic targeting of biotherapeutics
11.20-11.45 Tarit Mukhopadhyay University College London Manufacturing the future at less than a $1 a dose and meeting global health needs
11.45-11.55 Andrew Peden University of Sheffield Developing a toolkit for determining the manufacturability of new therapeutics in CHO cells 
11.55-12.20 Nathan Lewis University of California San Diego, USA Engineering CHO cells with enhanced traits with multiplex genome editing

12.20-13.25 Lunch

Building expression systems into optimised process chaired by Yvonne Genzel
13.25-13.50 Gary Finka GlaxoSmithKline Developing a next-generation cell line development platform through targeted automation, analytics and informatics
13.50-14.15 Sophia Hober Royal Institute of Technology, Sweden The human secretome project
14.15-14.25 Mayur Parekh Teesside University Improved preservation of biologics by continuous intensified lyophilisation
14.25-14.35 James Winterburn University of Manchester From bench to business with UKRI funding
14.35–15.00 Natalio Krasnogor Newcastle University Synthetic portabolomics: bridging the gap between the lab bench and industry to speed up the development of new biotech products

15.00-15.40 refreshment break and networking

The clinic and beyond chaired by Laura Palomares
15.40-16.05 Caroline Barelle Elasmogen soloMERä Biologics: Site-specific therapeutic biologics for the treatment of inflammatory disease
16.05-16.20 Simon Saxby Leaf Expression Systems Plant produced biologics – process economics
16.20-16.30 Michael Plevin University of York Can an archaeal helicase enhance the performance of a nanopore DNA sequencer?
16.30-16.40 Pavlos Kotidis Imperial College London A mathematical model to describe CHO cell growth and monoclonal antibody glycosylation

Hotel check-in
18.00 Poster session
20.00 Conference dinner

Thursday October 11th
Upstream meets downstream – rapid process development chaired by Cleo Kontoravdi
9.00-9.25 Paul Dalby University College London Analysis and control of protein dynamics and stability: downstream to formulation
9.25-9.50 Yvonne Genzel Max Planck Institute for Dynamics of Complex Technical Systems, Germany Intensified cell-based viral vaccine processes: from continuous to perfusion and to hybrid systems
9.50-10.15 Maiken Kristiansen MedImmune Nucleic acid production for biotherapeutics
10.15-10.25 Dave Brockwell University of Leeds Investigating the effects of hydrodynamic force on the structure and biological integrity of a viral vector gene therapy product
10.25-10.35 Davide Vito University of Kent Translation engineering through the non-coding genome in CHO cells
10.35-11.00 Pernille Harris Technical University of Denmark Solution structure and self-association of pharmaceutical proteins

11.00-11.40 refreshment break and networking

Molecular characterisation of process quality chaired by Alan Dickson
11.40-12.05 Mike Betenbaugh Johns Hopkins University, USA Glycoengineering of mammalian cell lines to improve product quality
12.05-12.30 Laura Palomares National Autonomous University of Mexico Challenges of bringing recombinant vaccines to the market: A case study for a influenza vaccine
12.30-12.40 Perdita Barran University of Manchester Top-down mass spectrometry methods for full characterisation of biopharmaceuticals
12.40-12.50 Rosa Morra University of Manchester Classical and non-classical secretion pathways in E. coli for periplasmic and extracellular recombinant protein production
12.50-13.15 Jonathan Bones The National Institute for Bioprocessing Research and Training, Ireland Characterisation of biopharmaceuticals using intact protein separations hyphenated to high resolution native mass spectrometry

13.15-14.00 Poster prizes and lunch

Timings may change due to logistical needs

 

Manufacturing ATMPs – moving from approvable to commercial success

Registration is now open for this conference organised by the Future Targeted Healthcare Manufacturing Hub, in partnership with the Knowledge Transfer Network (KTN), to be held on 18th September at Woburn House Conference Centre in London. The meeting will focus on the current UK innovation landscape for advanced therapies, in support of enabling gene and cell therapy products to go from approvable to commercially successful. We will also hear about translational research projects in support of manufacturing readiness, in addition to a future looking session regarding key challenges from clinical, regulatory and skills perspectives. The Hub and KTN partner to deliver this meeting enabling industry and academia engagement and collaboration, and showcasing of the relevant translational research being undertaken by the Hub in collaboration with industry.

We are expecting about 100 delegates on the day from the wider sector. The event is free to attend for the community. The agenda will be published soon.

Call for Posters
There will be a chance for researchers from both academia and industry to share and present relevant posters. Please note your interest on registration and use the free text box to indicate the title (or short descriptor).

Further information
Please note, places for this event are limited and if the meeting is oversubscribed, places will be prioritised for those who are technical practitioners in the sector. We may need to limit number of representatives from any one organisation.
For any queries please contact Marcel Kuiper